
- Oncology NEWS International Vol 11 No 5
- Volume 11
- Issue 5
VariSeed 7.0 Treatment Planning Tool for Permanent Seed Implant Brachytherapy
PALO ALTO, California-Varian Medical Systems has released VariSeed 7.0, the company’s newest treatment planning software for permanent seed implant brachytherapy used in treating prostate cancer. VariSeed 7.0 gives physicians the ability to use real-time images generated during the implant procedure to deliver precise accurate doses, the company said in a news release.
PALO ALTO, CaliforniaVarian Medical Systems has released VariSeed 7.0, the company’s newest treatment planning software for permanent seed implant brachytherapy used in treating prostate cancer. VariSeed 7.0 gives physicians the ability to use real-time images generated during the implant procedure to deliver precise accurate doses, the company said in a news release.
Using VariSeed 7.0, radiation oncologists can generate a treatment plan, use it to implant the seeds, and see how the radiation dose will develop within the patient’s anatomy while the patient is still in the operating room. This allows for fine-tuning and more precise adjustments on the spot, the company said.
VariSeed 7.0 also introduces the ability to superimpose different kinds of diagnostic images such as MRI and single photon emission computed tomography (SPECT), which show the extent of disease, with CT and ultrasound images, which show anatomy and positioning. This enables physicians to adjust implants according to an individual patient’s disease characteristics.
VariSeed 7.0 is now available to new customers and as a software upgrade to clinics that already use VariSeed for planning and documenting prostate seed implant dosimetry.
Articles in this issue
over 23 years ago
Prognosis Good for Local Recurrence After Lumpectomyover 23 years ago
Long-Term Use of Actiq Safe and Effective for Breakthrough Painover 23 years ago
Youth Exposed to Tobacco Promotionsover 23 years ago
Green Tea May Help Prevent Certain Gastrointestinal Cancersover 23 years ago
EGFR Inhibitor Effective as Salvage Therapy for NSCLCover 23 years ago
Targeted Filgrastim Support Allows Planned Chemotherapy Dosesover 23 years ago
Low Risk of CHF With Paclitaxel/Trastuzumab Adjuvant Rxover 23 years ago
Anxiety, Depression in Women at High Risk for Breast Cancerover 23 years ago
NCCN Updates its Treatment Guidelines for Breast Cancerover 23 years ago
Danny Glover ‘Acting’ as Spokesman for Anemia LifeLineNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.